HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
2-(p-methoxyphenyl)adenosine
structure
Also Known As:
CV 1674; CV-1674; 2-(4-methoxyphenyl)adenosine
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Purines: 651
Purine Nucleosides: 360
Adenosine: 12431
2-(p-methoxyphenyl)adenosine: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
Nucleosides: 6847
Purine Nucleosides: 360
Adenosine: 12431
2-(p-methoxyphenyl)adenosine: 1
Ribonucleosides: 49
Adenosine: 12431
2-(p-methoxyphenyl)adenosine: 1
Related Diseases
1.
Hypotension (Low Blood Pressure)
10/01/1977 - "
CV-1674 (250 and 500 microgram/kg) increased myocardial tissue blood flow (MBF) with a slight hypotension in a dose-dependent manner, whereas 2-Cl-ADS (100, 250 and 500 microgram/kg) increased MBF only with the highest dose concomitantly with marked hypotension and bradycardia.
"
2.
Bradycardia
10/01/1977 - "
ADS produced a marked bradycardia that was not evident with CV-1674.
"
10/01/1977 - "
CV-1674 (250 and 500 microgram/kg) increased myocardial tissue blood flow (MBF) with a slight hypotension in a dose-dependent manner, whereas 2-Cl-ADS (100, 250 and 500 microgram/kg) increased MBF only with the highest dose concomitantly with marked hypotension and bradycardia.
"